Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article that debuts and validates the application of Calder’s ‘3D Vaxlock’ platform technology.
news, journals and articles from all over the world.
Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article that debuts and validates the application of Calder’s ‘3D Vaxlock’ platform technology.